Control of extensively drug-resistant Pseudomonas aeruginosa co-harboring metallo-β-lactamase enzymes with oprD gene downregulation

被引:1
|
作者
El-Sherbiny, Gamal M. [1 ]
Basha, Amr Mohamad [2 ]
Mabrouk, Mona, I [2 ]
机构
[1] Al Azhar Univ, Fac Sci Boys, Dept Bot & Microbiol, Cairo, Egypt
[2] Egyptian Drug Author, Dept Microbiol, Natl Org Drug Control & Res, Giza, Egypt
关键词
Combinations; Treatment; XDR- Pseudomonas aeruginosa; Control of (XDR-CR Pseudomonas aeruginosa; SYNERGISTIC ACTIVITIES; COMBINATION; MECHANISMS; COLISTIN; IMIPENEM; RIFAMPICIN; STRAINS;
D O I
10.1016/j.ijmmb.2021.11.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: to study control and treatment of infection with extensive drug-resistant carbapenem-resistant Pseudomonas aeruginosa (XDR-CRPA). Methods: Eleven Pseudomonas aeruginosa (XDR-CRPA) strains used in this study were isolated from a clinical sample, identified, and antibiotics susceptibility recorded in a previous study. Real-time PCR (RT-PCR) was performed to determine the expression level of the OprD gene. Besides, a checkerboard technique was performed to assess the effect of polymyxin-B (PDX), colistin (COL), rifampicin (RIF), imipenem (IPM), and meropenem (MEM) during 2 and 3- dimensional antibiotic combinations. Further, the time-kill study was determined for the most potent combination against four representative strains, log io changes of viable cell counts were expressed as their mean value (+/- SD) values. Results: Molecular analysis by Real-time PCR revealed that the diminished expression level of OprD mRNA was overwhelming to various degrees. The checkerboard method demonstrated that the relevant synergism was achieved in 90.9% of strains for both carbapenem antibiotics during the triple combinations. While an additive effect was noted for all the dual regimen assays. Regarding time-kill experiments, a remarkable bactericidal effect with [99.9% killing rate] was observed toward only one strain whilst a bacteriostatic attitude was proven with >= 95% bacterial eradication against the three remaining strains. Conclusions: These findings underscore the promising implications of these combinations for treatment against XDR-Pseudomonas aeruginosa even they are resistant to carbapenems due to multiple mechanisms of action.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [31] Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
    Karagoz, Gul
    Kadanali, Ayten
    Dede, Behiye
    Sahin, Omer Torun
    Comoglu, Senol
    Altug, Sevda Babacan
    Naderi, Sait
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (01) : 93 - 94
  • [32] Cefiderocol and Intraventricular Colistin for Ventriculitis due to an Extensively Drug-Resistant Pseudomonas Aeruginosa
    Silva, Joao Melo e
    Oliveira, Diogo
    Louro, Joao A.
    Monteiro, Elisabete
    JOURNAL OF CRITICAL CARE MEDICINE, 2024, 10 (02): : 183 - 187
  • [33] High Rates of Extensively Drug-Resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis
    Gutierrez-Santana, Juan C.
    Geronimo-Gallegos, Armando
    Martinez-Corona, Monica B.
    Lopez-Lopez, Marisol
    Toscano-Garibay, Julia D.
    Cuevas-Schacht, Francisco
    Coria-Jimenez, Victor R.
    CURRENT MICROBIOLOGY, 2022, 79 (11)
  • [34] Extensively Drug-Resistant Pseudomonas aeruginosa Bacteremia in Solid Organ Transplant Recipients
    Bodro, Marta
    Sabe, Nuria
    Tubau, Fe
    Llado, Laura
    Baliellas, Carme
    Gonzalez-Costello, Jose
    Maria Cruzado, Josep
    Carratala, Jordi
    TRANSPLANTATION, 2015, 99 (03) : 616 - 622
  • [35] Molecular characterization of extensively drug-resistant hypervirulent Pseudomonas aeruginosa isolates in China
    Jun Li
    Mengli Tang
    Zhaojun Liu
    Yuhan Wei
    Fengjun Xia
    Yubing Xia
    Yongmei Hu
    Haichen Wang
    Mingxiang Zou
    Annals of Clinical Microbiology and Antimicrobials, 23
  • [36] Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosa
    Morelli, Morgan K.
    Kloosterboer, Amy
    Fulton, Scott A.
    Furin, Jennifer
    Newman, Nicholas
    Omar, Ahmed F.
    Rojas, Laura J.
    Marshall, Steven H.
    Yasmin, Mohamad
    Bonomo, Robert A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (07)
  • [37] Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China
    Li, Jun
    Zou, Mingxiang
    Dou, Qingya
    Hu, Yongmei
    Wang, Haichen
    Yan, Qun
    Liu, Wen'en
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
  • [38] Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China
    Jun Li
    Mingxiang Zou
    Qingya Dou
    Yongmei Hu
    Haichen Wang
    Qun Yan
    Wen’ en Liu
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [39] Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients
    Pena, C.
    Gomez-Zorrilla, S.
    Suarez, C.
    Dominguez, M. A.
    Tubau, F.
    Arch, O.
    Oliver, A.
    Pujol, M.
    Ariza, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2791 - 2797
  • [40] High Rates of Extensively Drug-Resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis
    Juan C. Gutiérrez-Santana
    Armando Gerónimo-Gallegos
    Mónica B. Martínez-Corona
    Marisol López-López
    Julia D. Toscano-Garibay
    Francisco Cuevas-Schacht
    Victor R. Coria-Jiménez
    Current Microbiology, 2022, 79